REGISTER
China Sets 11-Day Record in Combined Pig Liver-Kidney Transplant
A Chinese team has set a new world record by sustaining transplanted pig liver and kidney grafts in a human recipient for 11 days.

The new survival record for a combined xenogeneic liver-kidney transplant in the human body not only demonstrates China's maturity and leadership in xenotransplantation, but also gives researchers greater confidence to pursue longer-term and more complex xenograft studies.

On January 31, 2026, under the guidance of Academician Jiahong Dong, the xenotransplantation team led by Prof. Zhong Zeng at the First Affiliated Hospital of Kunming Medical University transplanted a liver and a kidney from a six-gene-edited pig into a brain-dead recipient.

The xenogeneic liver and kidney continued functioning for 11 days after transplantation, setting a world record for survival in combined pig liver-kidney transplantation. Of particular note, bile output from the transplanted liver approached normal physiologic levels, reportedly the best bile-secretory function yet seen in this kind of study.

Surgical breakthrough: a historic step in liver transplantation

The liver procedure, an orthotopic auxiliary partial liver transplant, was the core of the study. Soon after reperfusion, golden bile appeared in the bile duct, indicating that the graft had begun to function. During the continuous 11-day observation period, bile secretion remained stable, with average daily output above 150 mL and peak output above 200 mL.

The kidney transplant used a classic heterotopic technique. Once blood flow was restored, the graft kidney quickly turned pink and urine drained smoothly. During observation, urine output increased gradually, with total urine exceeding 4,000 mL and peak daily urine above 1,800 mL, reaching a normal physiologic range. Postoperative ultrasonography showed good perfusion of both transplanted organs.

Far-reaching significance: a Chinese solution to organ shortage

The donor pig came from a domestically bred medical pig line meeting designated-pathogen-free biosafety standards. Three pig antigen genes were knocked out, while two human complement-regulatory protein genes and one human coagulation-regulatory protein gene were inserted. This six-gene strategy directly addresses the two core barriers in xenotransplantation: immune rejection and coagulation disorders.

The entire project took place in a dedicated independent research campus within the hospital, using a specially configured operating room and intensive care unit. The team also dynamically monitored porcine viruses in the recipient and systematically collected pathogen data, generating important evidence for infection-risk management.

A technical validation closer to real clinical use

Unlike the full-liver replacement approach common in similar studies, this protocol preserved part of the recipient's own liver and allowed the xenogeneic and native livers to work together. This is closer to the bridge-therapy scenario envisioned for future clinical use, in which a pig liver temporarily supports a failing liver while the patient's own liver regenerates or while the patient waits for a human donor.

Even more noteworthy, the recipient already had liver insufficiency and acute renal insufficiency before surgery. Despite this double metabolic burden, the transplanted liver and kidney both began functioning rapidly and remained stable for 11 days. The investigators believe these findings provide persuasive support for future use in patients with end-stage organ failure.

The team said the study underwent strict ethical review, technical verification, and fully informed consent, and that the trial was ended as planned on day 11 at the family's request. With continued improvements in gene editing and immunosuppressive strategies, pig organs may one day bring new hope to countless patients with organ failure.

0
0
Loading